[LGND] YoY Annual Result on 31-Dec-2009 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
03-Mar-2010
Financial Year
2009
Quarter
31-Dec-2009 [#FY]
Profit Trend
YoY- 98.01%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 31,388 30,037 23,538 38,940 27,315 12,894 140,960 -22.12%
PBT -3,865 -2,930 -15,403 -9,872 -97,515 -53,456 -174,273 -46.96%
Tax -1,191 -13,103 -2,617 -7,924 -55 -18,697 -38,414 -43.92%
NP -527 10,176 -12,515 -1,948 -98,114 281,688 -31,743 -49.46%
Tax Rate - - - - - - - -
Total Cost 31,915 19,861 36,053 40,888 125,429 -268,794 172,703 -24.50%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin -1.68 33.88 -53.17 -5.00 -359.19 2,184.64 -22.52 -35.09%
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
EPS -0.03 0.52 -0.64 -0.10 -6.16 17.22 -2.36 -51.65%
EPS Diluted -0.03 0.52 -0.64 -0.10 -6.16 17.22 -2.36 -51.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.